Ï㽶ÊÓƵ

Diamond Therapeutics Signs Agreement with Ï㽶ÊÓƵ for Research on Low-Dose LSD

Published: 4 February 2021

TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement...

Active Startup: ANANDA

Published: 10 October 2019

Business Snapshot...

Message to the McGill research community about CFI projects

Published: 6 April 2020

On March 20, 2020, the Government of Quebec announced an immediate shutdown of constructions sites due to the COVID-19 pandemic. On April 7, it was announced that the date to resume construction...

Pages

Back to top